Topic: Austria

The following statement was issued today by the Biotechnology Industry Organization (BIO) regarding a proposal to establish a pathway for regulatory approval of biosimilars reportedly under consideration in the Senate Committee on Health, Education, Labor and Pensions (HELP): "The new proposal purports ...